» Articles » PMID: 22041456

Genomic Instability Induced by Mutant Succinate Dehydrogenase Subunit D (SDHD) is Mediated by O2(-•) and H2O2

Overview
Date 2011 Nov 2
PMID 22041456
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

SDHD mutations are associated with human cancers but the mechanisms that may contribute to transformation are unknown. The hypothesis that mutations in SDHD increase levels of superoxide leading to genomic instability was tested using site-directed mutagenesis to generate a truncated SDHD cDNA that was expressed in Chinese hamster fibroblasts. Stable expression of mutant SDHD resulted in 2-fold increases in steady-state levels of superoxide that were accompanied by a significantly increased mutation rate as well as a 70-fold increase in mutation frequency at the hprt locus. Overexpression of MnSOD or treatment with polyethylene glycol conjugated (PEG)-catalase suppressed mutation frequency in SDHD mutant cells by 50% (P<0.05). Simultaneous treatment with PEG-catalase and PEG-SOD suppressed mutation frequency in SDHD mutant cells by 90% (P<0.0005). Finally, 95% depletion of glutathione using l-buthionine-[S,R]-sulfoximine (BSO) in SDHD mutant cells caused a 4-fold increase in mutation frequency (P<0.05). These results demonstrate that mutations in SDHD cause increased steady-state levels of superoxide which significantly contributed to increases in mutation rates and frequency mediated by superoxide and hydrogen peroxide. These results support the hypothesis that mutations in SDHD may contribute to carcinogenesis by increasing genomic instability mediated by increased steady-state levels of reactive oxygen species.

Citing Articles

Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy.

Luo Z, Eichinger K, Zhang A, Li S Cancer Lett. 2023; 575:216396.

PMID: 37739209 PMC: 10591810. DOI: 10.1016/j.canlet.2023.216396.


Combinatorial Effects of the Natural Products Arctigenin, Chlorogenic Acid, and Cinnamaldehyde Commit Oxidation Assassination on Breast Cancer Cells.

Schuster C, Wolpert N, Moustaid-Moussa N, Gollahon L Antioxidants (Basel). 2022; 11(3).

PMID: 35326241 PMC: 8945099. DOI: 10.3390/antiox11030591.


Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration.

Dietrich P, Alli S, Mulligan M, Cox R, Ashbrook D, Williams R Neurobiol Dis. 2021; 162:105581.

PMID: 34871739 PMC: 8717869. DOI: 10.1016/j.nbd.2021.105581.


The Effects of Benoxacor on the Liver and Gut Microbiome of C57BL/6 Mice.

Simonsen D, Cady N, Zhang C, Shrode R, McCormick M, Spitz D Toxicol Sci. 2021; 186(1):102-117.

PMID: 34850242 PMC: 9019840. DOI: 10.1093/toxsci/kfab142.


Reactive Oxygen Species: A Promising Therapeutic Target for -Mutated Pheochromocytoma and Paraganglioma.

Hadrava Vanova K, Yang C, Meuter L, Neuzil J, Pacak K Cancers (Basel). 2021; 13(15).

PMID: 34359671 PMC: 8345159. DOI: 10.3390/cancers13153769.


References
1.
Loeb L, Springgate C, Battula N . Errors in DNA replication as a basis of malignant changes. Cancer Res. 1974; 34(9):2311-21. View

2.
Selak M, Armour S, MacKenzie E, Boulahbel H, Watson D, Mansfield K . Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005; 7(1):77-85. DOI: 10.1016/j.ccr.2004.11.022. View

3.
BEERS Jr R, SIZER I . A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952; 195(1):133-40. View

4.
Rustin P, Rotig A . Inborn errors of complex II--unusual human mitochondrial diseases. Biochim Biophys Acta. 2002; 1553(1-2):117-22. DOI: 10.1016/s0005-2728(01)00228-6. View

5.
Jackson A, Loeb L . The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 2001; 477(1-2):7-21. DOI: 10.1016/s0027-5107(01)00091-4. View